Meningococcal Polysaccharide Group A + Meningococcal Polysaccharide Group C + Meningococcal Polysaccharide Group W135 + Meningococcal Polysaccharide Group Y
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Meningococcal Polysaccharide Group A
meningococcal-polysaccharide-group-a - Meningococcal Polysaccharide Group C
meningococcal-polysaccharide-group-c - Meningococcal Polysaccharide Group W135
meningococcal-polysaccharide-group-w135 - Meningococcal Polysaccharide Group Y
meningococcal-polysaccharide-group-y
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| meningococcal polysaccharide group w135 + meningococcal polysaccharide group c + meningococcal polysaccharide group y + meningococcal polysaccharide group aAU | — | — |
| MenQuadfi meningococcal (Groups A,C,Y,W) polysaccharide tetanus toxoid conjugate vaccine, solution for injection, vialAU |
| Sanofi-Aventis Australia Pty Ltd |
Same combination in other markets
Cross-market comparison is not available for this grouped name.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.